{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:22:14Z","timestamp":1780878134325,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.thromres.2014.10.023","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T11:19:10Z","timestamp":1415099950000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio"],"prefix":"10.1016","volume":"135","author":[{"given":"Gary W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.10.023_bb0005","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.5858\/2002-126-1326-AD","article-title":"Antithrombin deficiency: issues in laboratory diagnosis","volume":"126","author":"Kottke-Marchant","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.thromres.2014.10.023_bb0010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.10.023_bb0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2141.1991.tb08584.x","article-title":"The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease","volume":"77","author":"Harper","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/jcp.44.6.477","article-title":"Screening for heparin binding variants of antithrombin","volume":"44","author":"Harper","year":"1991","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2009.08022.x","article-title":"Clinical guidelines for testing for heritable thrombophilia","volume":"149","author":"Baglin","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0049-3848(83)90333-X","article-title":"Antithrombin III Toyama: A hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis","volume":"31","author":"Sakuragawa","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.10.023_bb0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0038-1661305","article-title":"Antithrombin III \u201cNorthwick Park\u201d: a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity","volume":"53","author":"Howarth","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.10.023_bb0040","first-page":"885","article-title":"Guidelines on testing for the lupus anticoagulant","volume":"44","author":"Machin","year":"1991","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/107602960000600312","article-title":"Rapid genetic diagnosis in neonatal pulmonary artery thrombosis caused by homozygous Antithrombin Budapest 3","volume":"6","author":"Brown","year":"2000","journal-title":"Clin Appl Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.10.023_bb0050","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0021-9258(17)36071-4","article-title":"Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity","volume":"261","author":"Chang","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2014.10.023_bb0055","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2141.1995.tb08369.x","article-title":"Antithrombins Southport (99 Leu to Val) and Vienna (118 Gln to Pro): two novel antithrombin variants with abnormal heparin binding","volume":"89","author":"Chowdhury","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0060","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1613235","article-title":"Antithrombin \u2018DREUX\u2019 (Lys114Glu): a variant with complete loss of heparin affinity","volume":"88","author":"Mushunje","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.10.023_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1073\/pnas.81.2.289","article-title":"Antithrombin III Toyama: Replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability","volume":"81","author":"Koide","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2014.10.023_bb0070","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood.V81.5.1300.bloodjournal8151300","article-title":"Antithrombin III Nagasaki (Ser166-Pro): a heterozygous variant with defective heparin binding associated with thrombosis","volume":"81","author":"Okajima","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.10.023_bb0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF02592311","article-title":"Ischaemic stroke in congenital (type IIC) defective antithrombin III","volume":"23","author":"Martinelli","year":"1993","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.thromres.2014.10.023_bb0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0038-1650289","article-title":"Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency","volume":"75","author":"van Boven","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.10.023_bb0085","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1592\/phco.24.6.659.34745","article-title":"Argatroban therapy for antithrombin deficiency and mesenteric thrombosis: Case report and review of the literature","volume":"24","author":"Dager","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2014.10.023_bb0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajh.21893","article-title":"Laboratory tests for antithrombin deficiency","volume":"85","author":"Khor","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1751-553X.2011.01307.x","article-title":"The phenotypic and genetic assessment of antithrombin deficiency","volume":"33","author":"Cooper","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0100","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0021-9258(18)34900-7","article-title":"Heparin Cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma","volume":"257","author":"Tollefsen","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2014.10.023_bb0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.V61.1.111.111","article-title":"Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma","volume":"61","author":"Griffith","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.10.023_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0049-3848(82)90133-5","article-title":"Antithrombin assay - the use of human or bovine thrombin and the observation of a \"second\" heparin cofactor","volume":"25","author":"Friberger","year":"1982","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.10.023_bb0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ajcp\/89.4.515","article-title":"Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay","volume":"89","author":"Hortin","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0120","doi-asserted-by":"crossref","first-page":"50267","DOI":"10.1074\/jbc.M408774200","article-title":"The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism","volume":"279","author":"O'Keeffe","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2014.10.023_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1309\/AJCP7SBB6MQKHSFH","article-title":"Are the laboratory results (phenotype) indicative of a true genotype abnormality?","volume":"137","author":"Marlar","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2257.1997.00209.x","article-title":"Diagnosis strategies in activated protein C resistance: is genotyping still necessary?","volume":"19","author":"Biron","year":"1997","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.thromres.2014.10.023_bb0135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1751-553X.2011.01326.x","article-title":"Clinical multicenter evaluation of a new FXa-based Antithrombin assay","volume":"33","author":"Merz","year":"2011","journal-title":"Int J Lab Hematol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814005805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814005805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T17:45:53Z","timestamp":1717523153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814005805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0049384814005805"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.10.023","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}